Showing results (651-660 of 744) with videos related to
Sort By:
Pageof 75
British Journal of Haematology|September 1, 2001
Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangementsT Shimamoto, T Iguchi, K Ando, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|November 21, 2007
[Surgical treatment for pulmonary aspergillosis with hyper immunoglobulin-E syndrome; report of a case]Hiromasa Arai, Y Rino, K Fujii, et al.Infection and Immunity|November 24, 1999
Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1M Sugai, K Hatazaki, A Mogami, et al.Journal of Molecular and Cellular Cardiology|February 1, 1997
Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiencyK Yoshimine, M Horiuchi, S Suzuki, et al.Oncology Reports|February 19, 1999
A phase I study of cisplatin i.p. and carboplatin i.v. with G-CSF in patients with ovarian cancerS Adachi, K Ito, Y Itani, et al.The Annals of Thoracic Surgery|January 1, 1997
Aortic arch operation using selective cerebral perfusion for nondissecting thoracic aneurysmJ Hayashi, S Eguchi, K Yasuda, et al.British Journal of Haematology|January 11, 2005
Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligandH Hasegawa, Y Yamada, H Harasawa, et al.Annals of Surgical Oncology|March 11, 2015
A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic TreatmentH Fujikawa, K Sakamaki, T Kawabe, et al.The Annals of Thoracic Surgery|January 1, 1997
Operation for nondissecting aneurysm in the descending thoracic aortaJ Hayashi, S Eguchi, K Yasuda, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 24, 1999
[A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group]T Chou, T Ishiguro, K Imajo, et al.Pageof 75